Advanced Biomedical Research and Innovation

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Menstrual blood derived stromal stem cells augment CD4+ T cells proliferation

Introduction: One of the most controversial issues in reproductive biology is dealing with the fact that a fully functional immune system in women should simultaneously fight off the invading pathogens and tolerate semi-allograft fetus throughout the pregnancy. Indeed, a successful pregnancy is supposed to remain unresponsive to paternal antigens originating from semi-allograft fetus. Thus far, extensive attempts and studies have been performed to unravel immunosuppressive mechanisms involved in immunological tolerance of gestation. Endometrium undergoes immunological changes to estab- lish tolerance during the onset of pregnancy. Along with gestation initiation, such immune cells as Natural Killer cells (NKs), monocytes, Dendritic Cells (DCs) and T cells are recruited to the endometrium. The phe- no type of decidual immune cells changes in a way to cooperate with tolerance. Selected NK cells, for in-position, change into decidual NK cells (dNK) with a decreased cytotoxic and expanded secretary movement 1-3. Macrophage and NK cells together initiate tolerogenic DCs (tDCs) 4, which fundamentally advance Treg differentiation. Nevertheless, it has been reported that depleting Tregs causes only a 10% fetal loss in the first pregnancy of mice 5. Indeed, there is evidence that Fas (First apoptosis signal), Indoleamine 2,3-dioxygenase (IDO) and Programmed Death-Ligand 1 (PD-L1) suppress fetus antigen-specific effector T cells 6-8, but immuno- tolerance is not interrupted even if one of these factors is absent in allogeneic mating’s in Ido1−/− or Fasl−/− mice 6,9. Despite the fact that repetition and covering compensatory systems may clarify to a limited extent the before said marvel, one enticing speculation would be immunomodulation at the feto-maternal interface by non-invulnerable cells dwelling in the endometrium.

Special Features

Full Text


Track Your Manuscript

Media Partners